Clinical utility of Basophil and B-cell biomarkers for monitoring disease activity in food allergy and food oral immunotherapy

Theodore Kim, Richard L. Wasserman, Oral Alpan, Atul Shah, Douglas Jones
doi: https://doi.org/10.1101/2020.01.15.20017541

Article Information

doi 
https://doi.org/10.1101/2020.01.15.20017541
History 
  • January 23, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Theodore Kim1,*,
  2. Richard L. Wasserman2,
  3. Oral Alpan3,
  4. Atul Shah4 and
  5. Douglas Jones5
  1. 1Allergy Partners of Northern Virginia, Sterling, VA
  2. 2Allergy Partners of North Texas Research, Dallas, TX
  3. 3Amerimmune, Fairfax, VA, USA
  4. 4New York Food Allergy and Wellness Center, Centereach, NY
  5. 5Tanner Clinic, Layton, UT
  1. ↵*Corresponding Author: Theodore Kim, M.D., Allergy Partners of Northern Virginia, 14520 Avion Pkwy, Suite 150, Chantilly, VA 22151, tkim{at}allergypartners.com
Back to top
Posted January 23, 2020.
Download PDF
Data/Code
Email
Clinical utility of Basophil and B-cell biomarkers for monitoring disease activity in food allergy and food oral immunotherapy
Theodore Kim, Richard L. Wasserman, Oral Alpan, Atul Shah, Douglas Jones
medRxiv 2020.01.15.20017541; doi: https://doi.org/10.1101/2020.01.15.20017541
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area